“…They have become drugs of immense importance and having a variety of biological activities such antitumor (Xia et al, 2007;Vijaya et al, 2007), antianginal (Abadi and Eissa, 2003), antitubercular (Bonde and Gaikwad, 2004;Joshi et al, 2008), antihypertensive (Bhandari et al, 2009;Raparti et al, 2009), MAO enzyme inhibitor (Ke et al, 2008), antibacterial (Joshi et al, 2008. Since the p-hydroxybenzohydrazide, thiadiazole, and thiazolin (Xia et al, 2007;Vijaya et al, 2007) moieties were reported for their anticancer properties, the newly synthesized compounds may show similar pharmacological profile to classical anticancer drugs.…”